Tonix Pharmaceuticals (TNXP) Reports Q2 Loss of $0.50/Share

August 8, 2016 7:20 AM EDT
Get Alerts TNXP Hot Sheet
Trade TNXP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.50), versus ($0.73) reported last year.

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment